Antifungal-Associated Drug-Induced Cardiac Disease

Area of Science:

• Cardiology
• Pharmacology
• Toxicology

Background:

• Cardiomyopathies encompass dilated, hypertrophic, restrictive, and idiopathic types.
• Potential causes include myocarditis, conduction abnormalities, direct injury, and nutritional deficiencies.

Purpose of the Study:

• To investigate the link between echinocandin use and cardiac dysfunction.
• To explore the mechanistic pathways of echinocandin-induced cardiomyopathy.

Main Methods:

• Review of existing literature on echinocandin-related cardiac events.
• Analysis of proposed mechanisms for drug-induced myocyte injury.

Main Results:

• Evidence suggests echinocandin-related cardiac dysfunction is a mitochondrial disease.
• Focal direct myocyte injury is the proposed mechanism.
• Acute toxicity may result from high-dose central line administration (e.g., caspofungin, anidulafungin).

Conclusions:

• Echinocandins may induce cardiomyopathy via mitochondrial damage and myocyte injury.
• Acute high-dose exposure can cause toxicity; chronic low-dose exposure may lead to hypertrophic cardiomyopathy.
• Further studies are required to investigate chronic exposure effects.